Yang S, Lu S, Guo Y, Luan W, Liu J, Wang L
BMC Infect Dis. 2024; 24(1):449.
PMID: 38671341
PMC: 11046970.
DOI: 10.1186/s12879-024-09340-x.
Mara A, Gavitt T, Tulman E, Miller J, He W, Reinhardt E
NPJ Vaccines. 2022; 7(1):86.
PMID: 35906257
PMC: 9336141.
DOI: 10.1038/s41541-022-00513-w.
Wang J, Mao J, Chen G, Huang Y, Zhou J, Gao C
Medicine (Baltimore). 2021; 100(3):e23926.
PMID: 33545964
PMC: 7837868.
DOI: 10.1097/MD.0000000000023926.
Iwamoto Y, Anno T, Koyama K, Shirai R, Kaneto H, Tomoda K
Front Immunol. 2020; 11:574540.
PMID: 33042156
PMC: 7522505.
DOI: 10.3389/fimmu.2020.574540.
Cho Y, Han M, Kim W, Choi E, Choi Y, Yun K
PLoS One. 2019; 14(8):e0219463.
PMID: 31461462
PMC: 6713385.
DOI: 10.1371/journal.pone.0219463.
Decreased Interleukin-10 Responses in Children with Severe Mycoplasma pneumoniae Pneumonia.
Ding S, Wang X, Chen W, Fang Y, Liu B, Liu Y
PLoS One. 2016; 11(1):e0146397.
PMID: 26751073
PMC: 4708986.
DOI: 10.1371/journal.pone.0146397.
Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.
Matsuda K, Narita M, Sera N, Maeda E, Yoshitomi H, Ohya H
BMC Infect Dis. 2013; 13:591.
PMID: 24330612
PMC: 3883477.
DOI: 10.1186/1471-2334-13-591.
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.
Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y
Antimicrob Agents Chemother. 2013; 57(8):4046-9.
PMID: 23716043
PMC: 3719750.
DOI: 10.1128/AAC.00663-13.
Two cases of Mycoplasma pneumoniae pneumonia with A2063G mutation in the 23S rRNA gene in siblings.
Hong J, Chun J, Uh Y, Oh K, Kim J, Yoon K
Ann Lab Med. 2013; 33(1):65-8.
PMID: 23301225
PMC: 3535199.
DOI: 10.3343/alm.2013.33.1.65.
Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils.
Pang W, Lan X, Wang C
Chin J Integr Med. 2012; 18(4):283-7.
PMID: 22457139
DOI: 10.1007/s11655-012-1054-6.
Mycoplasma pneumoniae pneumonia in children.
Youn Y, Lee K
Korean J Pediatr. 2012; 55(2):42-7.
PMID: 22375148
PMC: 3286761.
DOI: 10.3345/kjp.2012.55.2.42.
Reactive oxygen species mediate Jak2/Stat3 activation and IL-8 expression in pulmonary epithelial cells stimulated with lipid-associated membrane proteins from Mycoplasma pneumoniae.
Choi S, Lim J, Shimizu T, Kuwano K, Kim J, Kim H
Inflamm Res. 2012; 61(5):493-501.
PMID: 22270622
DOI: 10.1007/s00011-012-0437-7.
Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia.
Chung H, Shin J, Ju M, Kim W, Kim S
Cytokine. 2011; 54(2):218-21.
PMID: 21356600
PMC: 7129854.
DOI: 10.1016/j.cyto.2011.02.008.
Three familial cases of drug-resistant Mycoplasma pneumoniae infection.
Kamizono S, Ohya H, Higuchi S, Okazaki N, Narita M
Eur J Pediatr. 2009; 169(6):721-6.
PMID: 19898978
DOI: 10.1007/s00431-009-1100-3.
Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.
Chmura K, Bai X, Nakamura M, Kandasamy P, McGibney M, Kuronuma K
Am J Physiol Lung Cell Mol Physiol. 2008; 295(1):L220-30.
PMID: 18487355
PMC: 2494795.
DOI: 10.1152/ajplung.90204.2008.
Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K
Antimicrob Agents Chemother. 2004; 48(12):4624-30.
PMID: 15561835
PMC: 529214.
DOI: 10.1128/AAC.48.12.4624-4630.2004.
Mycoplasma pneumoniae and its role as a human pathogen.
Waites K, Talkington D
Clin Microbiol Rev. 2004; 17(4):697-728, table of contents.
PMID: 15489344
PMC: 523564.
DOI: 10.1128/CMR.17.4.697-728.2004.